GO:0015035 protein-disulfide reductase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015035 protein-disulfide reductase activity catalyzes the reversible reduction of protein disulfide bonds to free thiols, a central reaction in redox homeostasis.
• The term covers enzymes such as protein disulfide isomerase (PDI), thioredoxin-like proteins, and hyperthermophilic protein disulfide oxidoreductases.
• PDI can act as both a reductase and an oxidase depending on substrate and redox environment, and its oxidase activity is linked to thrombus formation.
• ERO1 is a disulfide bond producer that supports oxidative protein folding and cancer progression, illustrating the opposing arm of the same redox cycle.
• Protein-disulfide reductase activity influences vitamin K epoxide reductase and coagulation biology, making it relevant to thrombosis and drug metabolism.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of these redox enzymes in disease.
Description
Protein-disulfide reductase activity (GO:0015035) is a molecular function that catalyzes the reaction in which a protein with oxidized disulfide bonds is converted to a protein with reduced sulfide groups. This reversible thiol-disulfide exchange is fundamental to redox regulation, protein folding, and cellular defense against oxidative stress. The QuickGO definition captures the core chemistry: a protein with reduced sulfide groups is in equilibrium with a protein with oxidized disulfide bonds, and enzymes annotated to this term drive that equilibrium in the reducing direction. Researchers study this activity because it controls the functional state of many secreted and membrane proteins, and its dysregulation is linked to cancer, thrombosis, and metabolic disease. The term includes synonyms such as protein disulfide oxidoreductase activity and peptide disulfide oxidoreductase activity, reflecting the broad substrate range of these enzymes. Understanding GO:0015035 is therefore essential for anyone modeling redox biology, protein quality control, or disulfide-based drug targets.
protein-disulfide reductase activity At A Glance
| GO ID | GO:0015035 |
|---|---|
| GO term | protein-disulfide reductase activity |
| Ontology | molecular_function |
| Synonym | protein disulfide oxidoreductase activity; peptide disulfide oxidoreductase activity; heme lyase disulfide oxidoreductase activity |
| Major function | Reduction of protein disulfide bonds to free thiols, enabling redox regulation and protein folding |
| Reaction direction | Reductive: oxidized protein disulfide to reduced protein thiols |
| Representative enzymes | Protein disulfide isomerase (PDI), thioredoxin-like proteins, hyperthermophilic disulfide oxidoreductases |
| Related activity | Protein disulfide oxidase activity (opposite direction), often in the same enzyme family |
| Cellular context | Endoplasmic reticulum, cytoplasm, and extracellular compartments |
What Is GO:0015035?
In simple terms, GO:0015035 describes enzymes that break disulfide bonds in proteins by reducing them back to thiol groups. The official definition is: Catalysis of the reaction: a protein with reduced sulfide groups = a protein with oxidized disulfide bonds. This activity is reversible and often works together with oxidase activities that form disulfide bonds, creating a redox cycle that maintains protein structure and function.
Why Is protein-disulfide reductase activity Important in Cell Biology?
Protein-disulfide reductase activity is important because it controls the redox state of cysteine residues that determine protein stability, activity, and interactions. Many secreted proteins, including coagulation factors and vitamin K epoxide reductase, depend on a balance between disulfide formation and reduction. In cancer, the disulfide bond producer ERO1 supports tumor growth, while PDI reductase activity can either promote or suppress thrombus formation depending on context. In hyperthermophiles, specialized disulfide oxidoreductases maintain protein stability under extreme conditions, offering insights into enzyme evolution. Because this activity is reversible and substrate-specific, it is a promising target for therapeutic modulation in thrombosis, cancer, and oxidative stress disorders.
• Regulates the redox state of cysteine residues in proteins, affecting folding and function.
• Supports vitamin K epoxide reductase activity and coagulation biology.
• Linked to thrombus formation through PDI oxidase activity and sulfenylation.
• ERO1, a disulfide bond producer, supports cancer progression and is a potential drug target.
• Thioredoxin reductase can use PDI as a substrate, connecting to broader antioxidant networks.
• Hyperthermophilic disulfide oxidoreductases reveal mechanisms of protein stabilization.
• Involved in dehydroascorbate reduction and thioltransferase pathways.
• Provides a reversible switch for redox signaling in oxidative stress responses.
• Enables functional studies of secreted and membrane proteins in disease models.
• Offers targets for CRISPR-based knockout and point-mutation studies of redox enzymes.
Molecular Mechanism of protein-disulfide reductase activity
Substrate recognition and thiol-disulfide exchange
In simple terms: The enzyme finds a disulfide bond in a target protein and swaps it with its own thiol group.
Enzymes with protein-disulfide reductase activity typically contain a CXXC motif in their active site. The first cysteine attacks the substrate disulfide, forming a mixed disulfide intermediate, which is then resolved by the second cysteine to release the reduced substrate and regenerate the enzyme. This thiol-disulfide exchange is reversible and depends on the redox potential of the enzyme and substrate.
Cofactors and redox partners
In simple terms: These enzymes often need helper molecules like thioredoxin or glutathione to keep working.
Protein disulfide reductase activity can be coupled to thioredoxin reductase, which reduces the enzyme after it oxidizes its substrate. In some systems, dehydroascorbate and thioltransferases contribute to maintaining the reduced state of the enzyme. The availability of NADPH and glutathione influences the overall reducing capacity of the cell.
Regulation by oxidative stress and sulfenylation
In simple terms: Oxidative stress can modify the enzyme itself, changing its activity.
Sulfenylation of cysteine residues links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formation. This post-translational modification can shift the enzyme between reductase and oxidase functions, depending on the cellular redox environment. Such regulation is critical in platelets and endothelial cells during thrombosis.
Opposing oxidase activity and redox balance
In simple terms: Some enzymes can also do the opposite reaction, forming disulfide bonds.
ERO1 is a protein disulfide bond producer that supports oxidative protein folding and cancer progression. The balance between reductase and oxidase activities determines the net redox state of substrate proteins. In hyperthermophiles, disulfide oxidoreductases maintain protein stability by favoring disulfide formation under extreme conditions.
Substrate diversity and physiological roles
In simple terms: These enzymes act on many different proteins, from plant regulators to human clotting factors.
Orange protein, a phytoene synthase regulator in plants, has protein disulfide reductase activity, showing the broad taxonomic range of this function. In humans, PDI reductase activity influences vitamin K epoxide reductase and coagulation. This substrate diversity makes GO:0015035 relevant across plant biology, microbiology, and human medicine.
Key Genes Involved in GO:0015035 protein-disulfide reductase activity
The following genes and proteins are representative of enzymes and regulators associated with protein-disulfide reductase activity (GO:0015035).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDI | Protein disulfide isomerase with reductase and oxidase activities | Thrombosis, vitamin K epoxide reductase regulation |
| ERO1 | Disulfide bond producer supporting oxidative folding | Cancer progression and ER redox homeostasis |
| TXN | Thioredoxin, reduces disulfide bonds in substrate proteins | Antioxidant defense and redox signaling |
| TXNRD1 | Thioredoxin reductase, regenerates reduced thioredoxin | Cancer and oxidative stress |
| ORP | Orange protein, phytoene synthase regulator | Plant carotenoid biosynthesis and redox regulation |
| VKORC1 | Vitamin K epoxide reductase, supported by PDI | Warfarin metabolism and coagulation |
| PDIA1 | PDI family member with reductase activity | Platelet function and thrombus formation |
| PDIA3 | PDI family member in ER | Protein folding and immune function |
| PDIA4 | PDI family member | ER stress and cancer |
| PDIA6 | PDI family member | Redox regulation in secretion |
| GLRX | Glutaredoxin, thioltransferase activity | Redox signaling and dehydroascorbate reduction |
| GSR | Glutathione reductase | Maintains reduced glutathione for redox cycles |
| SLC7A11 | Cystine transporter supporting glutathione synthesis | Oxidative stress and ferroptosis |
| NXN | Nucleoredoxin, thioredoxin-like protein | Redox regulation in development |
| PRDX1 | Peroxiredoxin, reduces peroxides using thioredoxin | Antioxidant defense |
| SOD1 | Superoxide dismutase, copper-zinc | Oxidative stress and neurodegeneration |
| CAT | Catalase, detoxifies hydrogen peroxide | Redox balance |
How Is protein-disulfide reductase activity Regulated?
Protein-disulfide reductase activity is regulated at multiple levels. The redox environment, including NADPH and glutathione levels, controls the reducing capacity available to these enzymes. Post-translational modifications such as sulfenylation can switch PDI between reductase and oxidase functions, linking oxidative stress to thrombus formation. Expression of ERO1 and PDI family members is influenced by ER stress and cancer-associated signaling, which can shift the balance between disulfide formation and reduction. In hyperthermophiles, temperature and protein stability requirements shape the evolution of disulfide oxidoreductases.
protein-disulfide reductase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDI | Thrombosis, coagulation | Platelet-specific knockout or point-mutation models |
| ERO1 | Cancer progression | Tumor xenograft with ERO1 overexpression or knockout |
| VKORC1 | Warfarin metabolism, coagulation | Knock-in of VKORC1 variants in hepatocytes |
| TXN | Oxidative stress, cancer | Thioredoxin knockout or overexpression in cancer cell lines |
| ORP | Plant carotenoid biosynthesis | Plant knockout or overexpression lines |
Thrombosis and cardiovascular disease
Protein disulfide isomerase oxidase activity, regulated by sulfenylation, promotes thrombus formation, and PDI reductase activity influences vitamin K epoxide reductase and coagulation. These findings link GO:0015035 to cardiovascular risk and antithrombotic drug development.
Cancer
ERO1, a disulfide bond producer, supports cancer progression by maintaining ER redox homeostasis, while PDI family members can promote tumor cell survival. Targeting the balance between disulfide formation and reduction is a potential anticancer strategy.
Oxidative stress and metabolic disorders
Thioltransferases and dehydroascorbate reduction pathways connect protein-disulfide reductase activity to cellular antioxidant defense. Dysregulation of these pathways contributes to oxidative stress-related diseases, including neurodegeneration and metabolic syndrome.
From protein-disulfide reductase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PDI reductase activity affect thrombosis? | PDI knockout or point-mutation in platelets |
| Can ERO1 overexpression drive tumor growth? | Cancer cell line with ERO1 overexpression |
| How does VKORC1 mutation alter warfarin response? | Knock-in of VKORC1 variants in hepatocytes |
| What is the role of ORP in phytoene synthase regulation? | Plant ORP knockout or overexpression |
| Does thioredoxin reductase substrate switching affect redox balance? | TXN or TXNRD1 knockout cells |
| How does sulfenylation regulate PDI oxidase activity? | Point mutation of cysteine residues in PDI |
How to Study the protein-disulfide reductase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Redox proteomics | Cysteine oxidation states and sulfenylation | Identifying substrates and regulatory modifications |
| Enzyme activity assay | Reductase activity using model substrates | Characterizing purified PDI or thioredoxin |
| CRISPR knockout screen | Gene essentiality and oxidative stress sensitivity | Discovering modifiers of disulfide reductase pathways |
| X-ray crystallography | Three-dimensional structure of oxidoreductases | Understanding catalytic mechanism and thermostability |
| Western blot | Protein expression and disulfide bond status | Validating knockout or overexpression models |
| Platelet aggregation assay | Thrombus formation and PDI function | Studying thrombosis mechanisms |
| NADPH consumption assay | Thioredoxin reductase activity | Measuring redox coupling |
| Plant transformation | ORP function in carotenoid biosynthesis | Plant genetics and metabolic engineering |
Redox proteomics and thiol labeling
Redox proteomics using thiol-reactive probes can identify substrates and cysteine modifications of protein-disulfide reductase enzymes. These methods measure the oxidation state of specific cysteines and can reveal sulfenylation events.
Enzymatic activity assays
In vitro assays using insulin or di-eosin-glutathione disulfide as substrates measure reductase activity of purified enzymes. Coupling to thioredoxin reductase and NADPH allows continuous monitoring of reducing capacity.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to oxidative stress or disulfide reductase inhibitors. These screens link GO:0015035 to cellular fitness and drug response.
Structural and biophysical analysis
Crystal structures and NMR studies of hyperthermophilic disulfide oxidoreductases reveal the structural basis of thiol-disulfide exchange and thermostability. These approaches inform inhibitor design and enzyme engineering.
How CRISPR Can Be Used to Study GO:0015035 protein-disulfide reductase activity
Knockout
CRISPR knockout of PDI, ERO1, or TXN can abolish protein-disulfide reductase activity and reveal its role in thrombosis, cancer, or oxidative stress. Knockout models are essential for distinguishing reductase from oxidase functions.
Point Mutation
Point mutations in the CXXC active site of PDI or thioredoxin can selectively eliminate reductase activity while preserving structure, allowing precise functional dissection. Such models help identify which cysteine residues are critical for catalysis.
Knock-in
Knock-in of disease-associated VKORC1 variants or tagged PDI alleles enables study of warfarin response and real-time tracking of enzyme localization. Knock-in models are valuable for pharmacogenomics.
Overexpression
Overexpression of ERO1 or PDI can enhance disulfide bond formation or reductase activity, respectively, and is used to model cancer progression and thrombus formation. Overexpression in plant systems can also probe ORP function.
How EDITGENE Supports protein-disulfide reductase activity Research
Researchers studying protein-disulfide reductase activity-related genes often need to determine whether a candidate gene is causally involved in redox regulation, disease progression, or drug response. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for protein-disulfide reductase activity research.
Frequently Asked Questions About protein-disulfide reductase activity
What is protein-disulfide reductase activity?
It is a molecular function (GO:0015035) that catalyzes the reduction of protein disulfide bonds to free thiols, reversing oxidative protein modifications.
What genes are involved in protein-disulfide reductase activity?
Key genes include PDI, ERO1, TXN, TXNRD1, VKORC1, and ORP, among others.
How is protein-disulfide reductase activity regulated?
It is regulated by redox environment, NADPH and glutathione levels, and post-translational modifications such as sulfenylation.
What diseases are linked to protein-disulfide reductase activity?
Thrombosis, cancer, and oxidative stress-related disorders are linked to this activity.
What is the difference between protein-disulfide reductase and oxidase activity?
Reductase activity reduces disulfide bonds, while oxidase activity forms them; some enzymes like PDI can do both.
How can I study protein-disulfide reductase activity in the lab?
Common methods include enzyme activity assays, redox proteomics, and CRISPR knockout models.
What is the role of PDI in thrombosis?
PDI oxidase activity, regulated by sulfenylation, promotes thrombus formation, while its reductase activity influences coagulation factors.
How does ERO1 support cancer?
ERO1 produces disulfide bonds that support oxidative protein folding and cancer cell survival.
Can CRISPR be used to study protein-disulfide reductase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function.
What model organisms are used for protein-disulfide reductase research?
Human cell lines, platelets, cancer xenografts, and plant models such as ORP in carotenoid biosynthesis.
Conclusion
Protein-disulfide reductase activity (GO:0015035) is a fundamental redox function that controls protein thiol-disulfide balance and influences thrombosis, cancer, and oxidative stress responses. Understanding its mechanism, regulation, and disease links requires precise genetic models. EDITGENE provides comprehensive CRISPR services to accelerate discovery in this field.
References
- 1. Oogo Y et al.. 2022. Orange protein, phytoene synthase regulator, has protein disulfide reductase activity.. Plant Signal Behav 17(1):2072094 PMID: 35699140
- 2. Chetot T et al.. 2022. Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity.. Biochem Cell Biol 100(2):152-161 PMID: 35007172
- 3. Zito E et al.. 2024. Fingerprint of the oxido-reductase ERO1: A protein disulfide bond producer and supporter of cancer.. Biochim Biophys Acta Rev Cancer 1879(1):189027 PMID: 38007054
- 4. Yang M et al.. 2023. Sulfenylation links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formation.. J Thromb Haemost 21(8):2137-2150 PMID: 37037379
- 5. Wells WW et al.. 1994. Dehydroascorbate reduction.. J Bioenerg Biomembr 26(4):369-77 PMID: 7844111
- 6. Lundström J et al.. 1990. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity.. J Biol Chem 265(16):9114-20 PMID: 2188973
- 7. Wells WW et al.. 1993. Thioltransferases.. Adv Enzymol Relat Areas Mol Biol 66:149-201 PMID: 8430514
- 8. Ladenstein R et al.. 2006. Protein disulfides and protein disulfide oxidoreductases in hyperthermophiles.. FEBS J 273(18):4170-85 PMID: 16930136
